SELLAS Life Sciences Group, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
SELLAS Life Sciences Group, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • SELLAS Life Sciences Group, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$7.33M, a 21.7% increase year-over-year.
  • SELLAS Life Sciences Group, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$32.8M, a 16.3% increase year-over-year.
  • SELLAS Life Sciences Group, Inc. annual Operating Income (Loss) for 2023 was -$37.9M, a 9.73% increase from 2022.
  • SELLAS Life Sciences Group, Inc. annual Operating Income (Loss) for 2022 was -$42M, a 65.9% decline from 2021.
  • SELLAS Life Sciences Group, Inc. annual Operating Income (Loss) for 2021 was -$25.3M, a 48.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$32.8M -$7.33M +$2.03M +21.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$34.8M -$7.62M +$1.43M +15.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$36.2M -$9.65M +$1.64M +14.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$37.9M -$8.18M +$1.27M +13.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$39.1M -$9.36M -$2.22M -31% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$36.9M -$9.05M -$427K -4.95% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$36.5M -$11.3M +$5.45M +32.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$42M -$9.45M +$2.17M +18.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$44.1M -$7.15M -$169K -2.42% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$44M -$8.62M -$4.17M -93.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$39.8M -$16.7M -$14.5M -645% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$25.3M -$11.6M -$7.46M -179% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 -$17.8M -$6.98M -$2.49M -55.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$15.3M -$4.45M -$186K -4.36% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$15.2M -$2.25M +$1.82M +44.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$17M -$4.16M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$4.49M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$4.27M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$4.06M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2017 -$23M -$8.58M -$17.3M -198% Oct 1, 2017 Dec 31, 2017 10-K 2018-04-13
Q3 2017 -$5.72M -$4.46M +$2.01M +31.1% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-09
Q2 2017 -$7.73M -$4.91M +$4.38M +47.1% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-14
Q1 2017 -$12.1M -$5.09M +$3.88M +43.3% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-10
Q4 2016 -$16M $8.74M +$16.3M Oct 1, 2016 Dec 31, 2016 10-K 2018-04-13
Q3 2016 -$32.3M -$6.47M +$2.16M +25% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$34.5M -$9.29M -$209K -2.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$34.3M -$8.97M -$56K -0.63% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$34.2M -$7.59M -$1.89M -33.1% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-15
Q3 2015 -$32.3M -$8.64M +$1.93M +18.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$34.3M -$9.08M +$6.7M +42.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$41M -$8.91M +$2.94M +24.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$43.9M -$5.7M +$1.3M +18.5% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-15
Q3 2014 -$45.2M -$10.6M -$3.67M -53.3% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$41.5M -$15.8M -$7.8M -97.6% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 -$33.7M -$11.8M -$5.24M -79.2% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 -$28.5M -$7M Oct 1, 2013 Dec 31, 2013 10-K/A 2016-04-15
Q3 2013 -$6.89M -$1.37M -24.7% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-05
Q2 2013 -$7.99M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 -$6.61M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-06
Q3 2012 -$5.53M Jul 1, 2012 Sep 30, 2012 10-Q/A 2013-11-07
Q2 2011 -$4.62M +$132K +2.78% Apr 1, 2011 Jun 30, 2011 10-Q 2011-08-15
Q2 2010 -$4.75M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.